about
Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductasesSteroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferationActivity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cMepartricin long-term administration regulates steroid hormone and adrenergic receptor concentrations in the prostate of aged ratsPharmacotherapy for benign prostatic hyperplasia.Biosynthesis of catalytically active rat testosterone 5 alpha-reductase in microinjected Xenopus oocytes: evidence for tissue-specific differences in translatable mRNA.Age-related physiological changes and their clinical significance.The residual nonadrenergic contractile response to nerve stimulation of the mouse prostate is mediated by acetylcholine but not ATP in a comparison with the mouse vas deferens.Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5 alpha-reductaseDNA barcode authentication of saw palmetto herbal dietary supplementsNovel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).Review of current and future approaches to the management of benign prostatic hyperplasia.Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate.Endocrine and adrenergic pharmacological intervention in diseases of the prostateOxytocin--its role in male reproduction and new potential therapeutic uses.Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis.The role of estrogens and estrogen receptors in normal prostate growth and disease.Metabolic factors associated with benign prostatic hyperplasiaProlactin and prolactin receptors are expressed and functioning in human prostate.Prostate cancer and acromegaly.IGF-I, insulin and prostate cancer.ABC of transfusion. Massive blood transfusion.Selective estrogen receptor modulators for BPH: new factors on the ground.Benign prostatic hyperplasia: the best treatment.Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia.Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models.The epidemiology of benign prostatic hyperplasia: a study in Greece.Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.Prostatic disorders in acromegalic patients experience of a Brazilian center.A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.Which testosterone replacement therapy?A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasiaRapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer.Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cells exposed to high concentrations of estradiol.Null genotypes at the GSTM1 and GSTT1 genes and the risk of benign prostatic hyperplasia: a case-control study and a meta-analysis.Prostatic cancer/benign prostatic hypertrophy. Subcellular distribution of estradiol/androgen receptors.History of weight and obesity through life and risk of benign prostatic hyperplasia.Prostate-specific antigen and prostate gland size in men receiving exogenous testosterone for male contraception.Partial sequencing and tissue distribution of the canine isoforms of steroid 5alpha-reductase type I and type II.
P2860
Q24558620-713C837C-0147-40CD-B5F8-596105348620Q24631073-6B3AFD69-F417-4ACE-AE33-0D354A53D979Q24794475-45140CBE-D9C6-4F2C-962E-28B0C6BC50B6Q28576448-540D4B05-01BA-4168-AF26-A9DECB85B288Q33608293-967A983D-54C9-424A-AD87-1A72FECE47C0Q33638390-D63068B8-B507-4968-AF5D-2F91D6F3FF63Q34110489-34265FA4-85A2-4CE6-99B0-64C82D1AB292Q34257555-5DD15E5F-E412-4E14-B4BD-60374AE47721Q34565758-FF8292A3-EE7E-43AF-ABA4-401E5DF242BAQ35068626-08CA6C88-08E4-4FC3-BFDC-58EAFB145AF2Q35089850-80F74CA1-9AFB-46D6-8B8C-D5E9CAC4D758Q35162908-95CF4E11-A7B8-4D64-BD41-C5A65D9A6227Q35206274-23D2038D-AAC2-430C-8C12-8DDB77A1FED8Q35803015-09ED957D-D7B1-4E27-A6CC-E6304D3E7CD7Q36377388-6D4DE31A-4A0F-4A1B-B994-CF2F458CD73AQ36401971-EE92D718-F90C-42E4-BEA9-68FF82E53F21Q36488068-0400C01F-452F-4948-9719-064F98C0061BQ37104427-BF36E701-2D59-42D1-97C1-75000EF15D0CQ37363252-1D55EB61-D39F-414E-B748-0B8342B03078Q37686151-AD75244B-91DE-4ABC-9427-60D7E7D024ECQ37686154-B267CA54-5AE7-4C5A-84A5-C08885E33CA1Q37807870-1FC4E9CE-BDA7-4D11-91C0-64D3494B960EQ38115066-750BDF97-1953-4995-BA60-73BD20AA6E3DQ38206081-03499C24-C349-4E9A-85A7-16C6807229FAQ38913900-46721380-7B0D-4F47-B1D8-92C2F2FCA383Q39446461-6B674CE7-342A-4E8E-878D-13165345FA52Q39516548-2D735C92-C950-407C-BFC5-B0307DE45595Q40109797-9C2001B3-1139-4BCD-BD14-226AE014A64FQ40123781-F5376AD6-48A1-4A82-977A-3FB3A21CB552Q40143114-B2FE24D6-F73A-49AB-B52E-2DFB900DBEBDQ42119766-2DA6AC95-3EB7-40F9-AE20-BFEB2228A9E7Q42249957-A7AA2B0E-811F-4613-9CFE-8E53EFABCEFFQ42531516-807FA9D2-1BB6-4CDD-80DF-C4E051857187Q42719159-9130907E-9E57-44B4-BBDC-229A54099CC3Q44259286-8AD020F0-58E9-47EC-BBD3-6A0F2FC4378CQ44535799-F3F1B02C-D3BA-4033-808B-E8D32E2C4611Q46417291-0237C1F0-BE68-4D8A-8ADF-5ED6AF820C91Q46511143-974661C9-9AA7-473A-BF14-D5B4F4DCD3A4Q47399237-748A2AFF-D4B9-4454-918C-F1B3E358F989Q47843013-21DAFFF9-30EA-485A-A953-7FBA7A6ACDB3
P2860
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
1980年论文
@zh
1980年论文
@zh-cn
name
The pathogenesis of benign prostatic hyperplasia.
@en
type
label
The pathogenesis of benign prostatic hyperplasia.
@en
prefLabel
The pathogenesis of benign prostatic hyperplasia.
@en
P1476
The pathogenesis of benign prostatic hyperplasia.
@en
P2093
J D Wilson
P304
P356
10.1016/0002-9343(80)90267-3
P407
P577
1980-05-01T00:00:00Z